Screener Summaries Updates Institutions Sign In More Updates › Other Events › MDXH Other Events · Jul 24, 2026
Mdxhealth SA received a notification from Nasdaq stating that its Market Value of Listed Securities was below the $35… MDXH MDxHealth SA
Mdxhealth SA received a notification from Nasdaq stating that its Market Value of Listed Securities was below the $35 million minimum requirement for the period from June 1, 2026, to July 17, 2026. The company has a 180-day compliance period ending January 19, 2027, to regain compliance. Mdxhealth is a urology-focused precision diagnostics company providing molecular information for prostate cancer diagnosis and treatment.
More from MDxHealth SA MDxHealth proposes reverse stock split with ratio ranging from 1-for-5 to 1-for-30 Oct 30, 2026 MDxHealth reports Q3 revenue of $22.7M, suspends full-year guidance Oct 16, 2026 MDxHealth SA reported a net loss of $20.4 million and revenue of $51.1 million for the six months ended June 30, 2026 Sep 3, 2026 MDxHealth SA issued and sold 44,052,862 ordinary shares in a registered direct offering at $0.454 per share to… Aug 13, 2026 MDxHealth SA reported second quarter 2026 revenue of $27.2 million, a 16% increase year-over-year and a $3.3 million… Aug 13, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
